Posted By News On September 28, 2016 - 5:58pm
Antipsychotic medications are associated with an increased risk of pneumonia in persons with Alzheimer's disease (AD), according to new research from the University of Eastern Finland. The risk of pneumonia was the highest at the beginning of antipsychotic treatment, remaining elevated also in long-term use. No major differences were observed between the most commonly used antipsychotics.
Posted By News On September 27, 2016 - 1:29pm
Researchers have demonstrated the ability to deliver a fully functional copy of the CLN3 gene to stem cells of patients with juvenile NCL, an inherited neurodegenerative disease in which a mutation in the CLN3 gene causes early-onset severe central vision loss. The gene therapy restored production of CLN3 protein in the stem cell-derived retinal neurons, as described in an article in Human Gene Therapy.
Posted By News On September 27, 2016 - 10:10am
Researchers at Karolinska Institutet have managed to produce the first molecular map of the genes that are active in the various cells of the human pancreas. They have also revealed differences in genetic activity between people with type 2 diabetes and healthy controls. The study, which is published in Cell Metabolism, was conducted in the AstraZeneca and Karolinska Institutet co-run Integrated Cardio Metabolic Centre, and in association with researchers from AstraZeneca.
Posted By News On September 21, 2016 - 2:59pm
In nuclear reactors, energetic neutrons slam into metal atoms that are ordered in a lattice, displacing them with enough force to trigger a cascade of collisions. Laurent Béland,Yuri Osetsky and Roger Stoller, of the Energy Dissipation to Defect Evolution Energy Frontier Research Center at the Department of Energy's Oak Ridge National Laboratory, modeled radiation damage and discovered that the number of defects ultimately created in a material correlates with atomic displacements that high-pressure shock waves generate early in the collision cascade.
Posted By News On September 21, 2016 - 1:29pm
Keeping energy-concentrating mirrors at solar thermal power plants free from dirt is both labor and time intensive. Researchers at Oak Ridge National Laboratory are working to address the challenge with lab-developed superhydrophobic coating technology.
Posted By News On September 21, 2016 - 1:29pm
A specially designed antidote to reverse acute, potentially life-threatening anticoagulant-related bleeding worked quickly, and was well-tolerated according to interim results of the ongoing ANNEXA-4 study.
Andexanet alfa reduced anticoagulant activity by roughly 90% within half an hour among patients with acute major bleeding while receiving a factor Xa (fXa) inhibitor, resulting in "excellent or good" homeostatis at 12 hours in most subjects, reported lead investigator Stuart J. Connolly, MD, from McMaster University, in Hamilton Ontario, Canada.
Posted By News On September 21, 2016 - 12:55am
Fluoride salt-cooled high-temperature reactors are a promising design in the next generation of nuclear energy production, and one of the first steps from concept to reality is underway at Oak Ridge National Laboratory.
Posted By News On September 18, 2016 - 7:10pm
The Global Medical Holography Market may reach USD 953.9 Million by 2021, at a CAGR of 33.7% from 2016 to 2021, according to a market survey by MarketsandMarkets.
Posted By News On September 16, 2016 - 2:18pm
The development of the smart power grid and the smart meter in our homes to accompany it brings several benefits, such as improved delivery and more efficient billing. Conversely, any digital, connected technology also represents a security risk. Writing in the International Journal of Smart Grid and Green Communications, UK researchers explain how a malicious third party that hacked into the metering system could manipulate en masse the data being sent back to the smart grid and perhaps trigger a power generation shortfall.
Posted By News On September 16, 2016 - 2:15pm
Around 5.4 million people currently receive treatment for asthma in the UK, of which 1.1 million are children.
To diagnose the condition doctors usually measure a person’s airflow lung capacity, however lung function tests can be inaccurate and do not reflect underlying changes associated with asthma. Other tests, such as blood, urine or sputum analysis can be distressing, particularly for younger patients.
The new test, developed in collaboration with Nottingham City Hospital, is completely painless and offers a one-stop diagnosis suitable for people of all ages.